Cargando…
Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
Mice bearing carcinogen-induced premalignant oral lesions were previously shown to have a pro-inflammatory phenotype, which is replaced with an immune inhibitory phenotype as lesions progress to cancer. Since Th17 cells are prominent at the premalignant lesion state and their levels are supported by...
Autores principales: | Caughron, Blaine, Yang, Yi, Young, M. Rita I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903614/ https://www.ncbi.nlm.nih.gov/pubmed/29664967 http://dx.doi.org/10.1371/journal.pone.0196034 |
Ejemplares similares
-
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer
por: Johnson, Sara D., et al.
Publicado: (2016) -
An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma
por: Woodford, Danielle, et al.
Publicado: (2014) -
Progress risk assessment of oral premalignant lesions with saliva miRNA analysis
por: Yang, Ya, et al.
Publicado: (2013) -
Immunological and classical subtypes of oral premalignant lesions
por: Foy, Jean-Philippe, et al.
Publicado: (2018) -
Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment
por: Levingston, Corinne A., et al.
Publicado: (2017)